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Abstract. 
 
Genetic defects in a number of components 
of the dystrophin–glycoprotein complex (DGC) lead to 
distinct forms of muscular dystrophy. However, little is 
known about how alterations in the DGC are mani-
fested in the pathophysiology present in dystrophic 
muscle tissue. One hypothesis is that the DGC protects 
the sarcolemma from contraction-induced damage. Us-
ing tracer molecules, we compared sarcolemmal integ-
rity in animal models for muscular dystrophy and in 
muscular dystrophy patient samples. Evans blue, a low 
molecular weight diazo dye, does not cross into skeletal 
muscle fibers in normal mice. In contrast, 
 
mdx
 
 mice, a 
dystrophin-deficient animal model for Duchenne mus-
cular dystrophy, showed significant Evans blue accu-
mulation in skeletal muscle fibers. We also studied 
Evans blue dispersion in transgenic mice bearing differ-
ent dystrophin mutations, and we demonstrated that 
cytoskeletal and sarcolemmal attachment of dystrophin 
might be a necessary requirement to prevent serious fi-
ber damage. The extent of dye incorporation in trans-
genic mice correlated with the phenotypic severity of 
similar dystrophin mutations in humans. We further-
more assessed Evans blue incorporation in skeletal 
muscle of the 
 
dystrophia muscularis
 
 (
 
dy
 
/
 
dy
 
) mouse and 
its milder allelic variant, the 
 
dy
 
2J
 
/
 
dy
 
2J
 
 mouse, animal 
models for congenital muscular dystrophy. Surpris-
ingly, these mice, which have defects in the laminin 
 
a
 
2-
chain, an extracellular ligand of the DGC, showed little 
Evans blue accumulation in their skeletal muscles. 
Taken together, these results suggest that the patho-
genic mechanisms in congenital muscular dystrophy are 
different from those in Duchenne muscular dystrophy, 
although the primary defects originate in two compo-
nents associated with the same protein complex.
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1. 
 
Abbreviations used in this paper
 
: CMD, congenital muscular dystrophy;
DGC, dystrophin–glycoprotein complex; DMD, Duchenne muscular dys-
trophy; EBD, Evans blue dye; H&E, hematoxylin and eosin.
 
M
 
utations 
 
in several components of the dystro-
phin–glycoprotein complex (DGC)
 
1
 
 are known
to be involved in the pathogenesis of muscular
dystrophies (Ozawa et al., 1995; Straub and Campbell,
1997). This oligomeric complex connects the subsarcolem-
mal cytoskeleton to the extracellular matrix (Ervasti and
Campbell, 1993). The intracellular link of the DGC is the
membrane-associated cytoskeletal protein dystrophin, the
protein product of the Duchenne muscular dystrophy
(DMD) gene (Hoffman et al., 1987). The high density of
dystrophin in the subsarcolemmal cytoskeleton (Ohlen-
dieck and Campbell, 1991
 
a
 
; Ohlendieck et al., 1991
 
b
 
), its
homology to 
 
a
 
-actinin and spectrin (Koenig et al., 1988;
Dhermy, 1991), its costameric organization (Porter et al.,
1992; Straub et al., 1992), and its expression at the myoten-
dinous junction (Tidball, 1991) strongly suggest that it
plays an important structural role in muscle fibers. Dystro-
phin binds with its amino-terminal and rod domain to ac-
tin (Rybakova et al., 1996) and with its carboxy terminus
to the integral membrane protein 
 
b
 
-dystroglycan (Suzuki
et al., 1994; Jung et al., 1995). The peripheral membrane
glycoprotein 
 
a
 
-dystroglycan, a receptor for the heterotri-
meric basement membrane protein laminin-2, binds to 
 
b
 
-dys-
troglycan and so completes the connection from the inside
to the outside of the cell (Henry and Campbell, 1996). Mu-
tations in the 
 
LAMA2
 
 gene, encoding the 
 
a
 
2 chain of
laminin-2, have been characterized in a form of congenital
muscular dystrophy (CMD) linked to chromosome 6q
(Tomé et al., 1994; Helbling-Leclerc et al., 1995; Nissinen
et al., 1996).
It has been proposed that the initial event in muscle cell
necrosis in DMD was the focal breakdown of the plasma-
lemma (Mokri and Engel, 1975; Schmalbruch, 1975; Car-
penter and Karpati, 1979; Weller et al., 1990). Evidence
for leakage of intracellular contents out of dystrophic or
damaged muscle cells is provided by elevated serum levels
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of muscle enzymes (Rosalki, 1989) and growth factors
(D’Amore et al., 1994; Kaye et al., 1996). Simultaneously,
this loss of sarcolemmal integrity allows influx of mole-
cules into muscle fibers. In particular, elevated calcium
levels have been noted in dystrophin-deficient skeletal
muscle (Bodensteiner and Engel, 1978; Gillis, 1996). One
or both of these events may contribute to the pathogenesis
of muscular dystrophy.
To study altered sarcolemmal permeability in dystro-
phic muscle fibers, we injected animal models for muscular
dystrophy with Evans blue dye (EBD). The tetrasodium
diazo salt Evans blue, also called T-1824, is a membrane-
impermeant molecule that can be used in determining
blood volume (Reeve, 1957). This in vivo tracer technique
provides information about certain structural and dynamic
features of normal and pathological skeletal muscles (Mat-
suda et al., 1995).
For the tracer injection, we used 
 
mdx
 
 mice, transgenic/
 
mdx
 
 mice, 
 
dy
 
/
 
dy
 
, and 
 
dy
 
2J
 
/
 
dy
 
2J
 
 mice. The 
 
mdx
 
 mouse is a
dystrophin-deficient animal model for X-linked DMD
(Bulfield et al., 1984). It has been reported that the dystro-
phin mutation in the 
 
mdx
 
 mouse leads to an associated re-
duction of DGC components (Ohlendieck and Campbell,
1991b). We also injected four different transgenic/
 
mdx
 
mice that have been shown to result in different skeletal
muscle phenotypes (Rafael et al., 1994; Phelps et al., 1995;
Corrado et al., 1996; Rafael et al., 1996). These mice en-
abled us to analyze regions of dystrophin that are critical
for maintaining sarcolemmal integrity. One of the trans-
genic animals expressed only the COOH-terminal isoform
of dystrophin (Dp71), which is encoded by exons 63–79.
These Dp71 mice display proper localization of the DGC
at the sarcolemma, but still show a dystrophic phenotype
(Cox et al., 1994; Greenberg et al., 1994). The other three
transgenic/
 
mdx
 
 mice we injected were generated by ex-
pressing “full length” dystrophin constructs, but with con-
secutive deletions within the amino terminal domain (
 
D
 
3-7;
Corrado et al., 1996), the rod domain (
 
D
 
17-48; Phelps et
al., 1995), and the carboxy-terminal domain (
 
D
 
71-74; Rafael
et al., 1994, 1996). Mice missing exons 71–74 or exons 17–48
of the dystrophin gene display a markedly milder pheno-
type than 
 
mdx
 
 mice despite the expression of moderate
levels of dystrophin. In contrast to deletions of exons 71–74
or in the central rod domain, proteins with a deletion in
the actin-binding NH
 
2
 
 terminus must be expressed at high
levels to prevent a dystrophic phenotype (Corrado et al.,
1996).
Furthermore, we examined the 
 
dy
 
/
 
dy
 
 and the 
 
dy
 
2J
 
/
 
dy
 
2J
 
mice. These murine diseases are inherited in an autosomal
recessive fashion and have been studied as models for hu-
man laminin 
 
a
 
2 chain–deficient CMD (Sunada et al., 1994;
Xu et al., 1994
 
b
 
), whereby the 
 
dy
 
2J
 
/
 
dy
 
2J
 
 mouse represents
the milder allelic variant of the 
 
dy
 
/
 
dy
 
 mouse (Sunada et
al., 1995). The 
 
Lama2
 
 gene on mouse chromosome 10 was
closely mapped to the 
 
dy
 
/
 
dy
 
 locus (Sunada et al., 1994),
and a single in-frame deletion eliminating 57 amino acids
was discovered in the 
 
a
 
2 chain transcript in 
 
dy
 
2J
 
/
 
dy
 
2J
 
 mice
(Sunada et al., 1995). A principal goal of our studies was to
determine whether deficiency of the extracellular ligand of
the DGC, laminin-2, had similar effects on sarcolemmal
integrity as deficiency of its intracellular connecting link,
dystrophin.
 
Materials and Methods
 
Mice
 
Normal control, the original 
 
mdx
 
 mutant, and 
 
dy
 
2J
 
/
 
dy
 
2J
 
 mice were bred at
the University of Iowa from stocks originally obtained from the Jackson
ImmunoResearch Laboratories, Inc. (Bar Harbor, ME). All mice are on a
C57BL/10 background. The 
 
dy
 
/
 
dy
 
 mice were also obtained from the Jack-
son Laboratories. The transgenic/
 
mdx
 
 mouse strains were maintained at
the University of Michigan. Control and disease animals were matched by
age and gender. The age range of the mice was between 4 wk and 1 yr. All
animal studies were authorized by the Animal Care Use and Review
Committee of the University at Iowa.
 
Evans Blue Injection
 
EBD was injected either into the tail vein of the mice or into the perito-
neal cavity without anesthesia. For the assessment of EBD uptake into
muscle fibers, intravenous administration of the dye was preferred. Non-
specific coloration of the diaphragm and the abdominal muscles was
avoided by this route of injection. EBD was dissolved in PBS (0.15 M
NaCl, 10 mM phosphate buffer, pH 7.4) and sterilized by passage through
membrane filters with a 0.2-
 
m
 
m pore size. The concentration of the in-
jected dye was 0.5 mg EBD/0.05 ml PBS. Animals were injected with 50 
 
m
 
l
of this solution per 10 g body wt. 3–6 h after injection, the mice were killed
by cervical dislocation. The skin of the mice was removed, and the animals
were visually inspected for dye uptake into skeletal muscles, indicated by
blue coloration. To better characterize dye uptake in distinct muscles of
injected animals, we investigated cryosections of the femoral quadriceps,
the sural triceps, the pectoral, the diaphragm, and the cardiac muscle. Ad-
ditional skeletal muscle samples were taken if the muscle showed blue col-
oration. Muscle sections from EBD-injected animals were incubated in
ice-cold acetone at 
 
2
 
20
 
8
 
C for 10 min, washed 3
 
3
 
 10 min with PBS, and
mounted with Vectashield mounting medium (Vector Laboratories, Inc.,
Burlingame, CA). By fluorescence microscopy analysis, EBD staining
showed a bright red emission. Fiber counts of EBD-positive muscle fibers
were done independently by two investigators on 7-
 
m
 
m cryosections of
dye injected mice. All sections were examined and photographed under
an Axioplan fluorescence microscope (Carl Zeiss, Inc., Thornwood, NY)
or a MRC-600 laser scanning confocal microscope (Bio Rad Laboratories,
Hercules, CA).
 
Antibodies
 
For immunofluorescence analysis of albumin, the AIAG3140 rabbit anti–
mouse albumin antibody conjugated to FITC (Accurate Chemical & Sci-
entific Corp., Westbury, NY) was used at a concentration of 1:75. Staining
for Igs was performed with biotinylated anti–mouse IgG (H
 
1
 
L), biotiny-
lated anti–mouse IgM, biotinylated anti–human IgG (H
 
1
 
L), and biotiny-
lated anti–human IgM (Vector Laboratories). All anti-Ig antibodies were
used at a concentration of 1:500. A monoclonal antibody VIA4
 
2
 
A3 against
dystrophin (Ervasti et al., 1990) and a polyclonal rabbit antibody against
the 
 
a
 
2 chain of laminin (Allamand et al., 1997) were used for screening
purposes of mouse and patient samples. Biotinylated antibodies were de-
tected using streptavidin conjugated to either Texas red or FITC (Vector
Laboratories).
 
Immunofluorescence Microscopy
 
Muscle tissue from DMD and CMD patients was obtained from diagnos-
tic muscle biopsies. The clinical diagnosis of DMD was confirmed by com-
plete absence of dystrophin expression in muscle tissue. The clinical diag-
nosis of CMD was confirmed by white matter changes on brain magnetic
resonance images and by reduction or deficiency of laminin 
 
a
 
2 chain ex-
pression in muscle tissue. Normal human control muscle was received
from patients undergoing orthopedic surgery not related to neuromuscu-
lar disorders. Immunofluorescence microscopy of 7-, 15-, and 30-
 
m
 
m cryo-
sections from skeletal and cardiac muscle was performed as described pre-
viously (Ohlendieck et al., 1991
 
a
 
).
Cryosections for IgG and IgM staining were preincubated for 30 min
with 5% BSA in PBS, followed by a 1-h incubation with biotin-labeled
goat anti–mouse IgG or IgM antibodies. The sections were washed 3
 
3
 
 for
5 min with 1% BSA/PBS, incubated with FITC-conjugated streptavidin,
and after a final wash, mounted with Vectashield mounting medium (Vec-
tor Laboratories). For albumin staining, the sections were blocked with 
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1% gelatin in PBS for 15 min, washed in PBS 
 
1
 
 0.2% gelatin, and incu-
bated for 1 h in PBS 
 
1
 
 1% normal goat serum with a rabbit anti–mouse al-
bumin FITC-conjugated antibody. Histochemical examination of muscle
tissue was performed by hematoxylin and eosin (H&E) staining as de-
scribed (Dubowitz, 1985).
 
Results
 
Loss of Sarcolemmal Integrity in mdx Mice
 
Within seconds after intravenous injection of EBD, discol-
oration of all animals was observed. A successful injection
of the dye was indicated by the blue coloration of ears and
paws. Control mice did not show dye uptake into their
skeletal muscles by visual inspection. In EBD-injected
control mice, the presence of EBD in the perivascular
spaces was seen microscopically when the muscle sections
were inspected without any washing steps. There were
very few single fibers with a positive dye staining on sec-
tions of control animals, which were otherwise EBD nega-
tive (Table I).
In the 
 
mdx
 
 mutant, administered EBD always resulted
in blue discoloration of skeletal muscles (Fig. 1). This re-
sult was independent of the age of the animals used. The
accumulation of EBD tended to be more intense at certain
anatomical sites, forming a characteristic topographic pat-
tern of staining. Areas of blue staining appeared mainly
within the regions of the proximal limb muscles, as well as
the pelvic and the shoulder girdle (Fig. 1). The dye was
particularly incorporated in gluteal, femoral quadriceps,
and the ischiocrural muscles (hind limbs) and sometimes
the pectoral and the triceps brachii muscles (forelimbs; Fig.
1). Affected muscles were not stained homogeneously, but
they typically showed blue strands representing damaged
muscle fibers. In a longitudinal alignment, these strands
could be seen throughout the entire length of the muscles
(Fig. 1). Although there was a general topographic distri-
bution of the dye in skeletal muscles of 
 
mdx
 
 mice, perme-
ability of a given muscle region varied from animal to ani-
mal and even between opposing limbs within the same
animal. We found differences in both the intensity and the
extent of stained regions in left and right limbs (Fig. 1 
 
b
 
).
In addition to the proximal limb muscles, we also found
discoloration of the external oblique muscle of the abdo-
men, the longest thoracic and lumbar muscles, the cutane-
ous muscle of the trunk (Fig. 1 
 
c
 
), and in intercostal mus-
cles (Fig. 2 
 
c
 
). Anterior tibial muscles in 
 
mdx
 
 mice were
often spared from dye staining. In contrast, the diaphragm
of 
 
mdx
 
 mice showed areas of dye incorporation in all
tested animals (Fig. 2 
 
e
 
). Because of the variability in dye
accumulation and distribution, there was no significant dif-
ference in the staining pattern among mice that were 4–52
wk old.
Figure 1. Macroscopic evaluation of Evans blue staining after intravenous dye injection into two 9-wk-old mdx littermates (mouse 1, a
and b; mouse 2, c and d). The mice were fixed in a 8% formaldehyde solution 6 h after the dye injection. EBD staining in mouse 1 (a and
b) showed staining mainly within the regions of the pelvic girdle muscles. In particular, the dye was incorporated in the gluteal and the
femoral quadriceps muscles. Plasma membrane permeability for Evans blue varied from animal to animal and even from limb to limb in
the same animal. In mouse 1, we found differences in both the intensity and the extent of stained regions in the left and right triceps
brachii muscles (a and b, arrows). Besides dye uptake in proximal limb muscles, we also found discoloration of the external oblique mus-
cle of the abdomen, the longest thoracic and lumbar muscles, and the cutaneous muscles of the trunk (c and d). Affected muscles were
not stained homogeneously, but they typically showed blue strands according to damaged muscle fibers. Anterior tibial muscles in mdx
mice were often macroscopically spared from dye staining (a and c). 
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In 
 
mdx
 
 mice, skeletal muscles that visually showed dye
uptake were always EBD positive by fluorescence micros-
copy analysis (Fig. 2 
 
a
 
). In most of the cases, the intracellu-
lar staining was diffusely distributed across the myofiber
cytoplasm, although sometimes the fiber periphery was
more strongly stained than the center of the fiber. Further-
more, the intensity of the dye signal showed differences
between fibers (Fig. 2, 
 
a–e
 
). These findings were also de-
tected on 15- and 30-
 
m
 
m cross-sections and on longitudinal
sections (Fig. 2). Most of the EBD-positive fibers showed
intense staining, whereas in some others, the signal was
faint. Transverse cryosections of blue discolored muscles
never showed EBD in all fibers of a section. Instead, the
frequency of EBD fibers in a given muscle varied from an-
imal to animal and from muscle to muscle, reflecting the
results of visual inspection (Fig. 1). In transverse sections
of the 
 
mdx
 
 femoral quadriceps muscle, the mean fre-
quency of dye-positive fibers was 
 
.
 
10% of the total fiber
number (Table I), with a maximum of .70% positive fibers
(Fig. 2 a).
In transverse sections, the dye-positive mdx fibers oc-
curred either singly or, more often, in groups. The grouped
EBD-positive fibers were one of the most striking features
of dye staining in mdx mice (Fig. 2). Although EBD-posi-
tive fibers sometimes showed signs of necrosis in the H&E
staining, there was no clear correlation between dye-posi-
tive fibers and a uniform morphological feature (Fig. 2, e
and f). In contrast to a previous report (Matsuda et al.,
1995), we also found EBD-negative hypercontracted fi-
bers besides positive hypercontracted fibers (Fig. 2, e and
f, arrows) and therefore considered these to have an intact
sarcolemma. Fibers with distinctive necrotic features in
H&E seemed to be always EBD positive, no matter which
animal was injected (Fig. 2, e and f, arrowheads). On longi-
tudinal sections, we could demonstrate that dye uptake
was not confined to a small part of the fiber, but appeared
over long segments of the entire muscle cell (Fig. 2 d).
Evans Blue Staining in Cardiac Muscle of mdx Mice
We also examined cardiac muscle from all injected ani-
mals, since cardiac involvement is a common feature in
Figure 2. EBD (a–e) and
H&E staining (f) on 7-mm (a,
b, e, and f) and 15-mm (c and
d) skeletal muscle cryosec-
tions from 8- (a, b, e, and f)
and 16-wk-old (c and d) in-
travenously (a, b, e, and f)
and intraperitoneally (c and
d) injected mdx mice. In
some animals, the number of
dye-positive fibers in the
femoral quadriceps muscle
was  .70% (a). b shows a
magnification of a in which
the fascia demarcates a
highly damaged muscle re-
gion from the unaffected ad-
jacent muscle. Other muscles,
including the intercostal
muscles (c, white asterisks in-
dicate rips) and gluteal mus-
cles (d, longitudinal section)
took up the dye. EBD stain-
ing in mdx diaphragm (e)
demonstrated variation in
the dye-positive fibers. Dye
positive fibers in the corre-
sponding H&E staining (f)
revealed morphological fea-
tures of normal fibers (aster-
isk) as well as of necrosis (ar-
rowhead). Hypercontracted
fibers did not necessarily in-
dicate membrane damage,
since some of them did not
take up EBD (arrows). Bars,
100 mm.Straub et al. Sarcolemmal Damage in Muscular Dystrophy 379
many forms of muscular dystrophy. Control mice never
showed EBD-positive fibers in cardiac muscle tissue. In
contrast, 8 out of 16 mdx mice had EBD-positive lesions in
the myocardium. In one 4-wk-old mouse, large areas of
the cardiac section showed EBD uptake into cardiac mus-
cle fibers (Fig. 3 a), whereas in the other mice, ranging
from 6 to 52 wk of age, regions of variable size in the ven-
tricular wall were affected (Fig. 3, b and c). On sections
stained with H&E, the EBD-positive areas showed char-
acteristic features of myocardial damage, with a strong in-
flammatory component (data not shown). Myocardial
EBD staining in intraperitoneally injected mice (Fig. 3 c)
provided evidence that the fiber damage was caused by
the underlying disease and not by volume overload of in-
travenously administered dye, leading to a cardiac infarct.
Presence of Serum Proteins in Damaged Skeletal 
Muscle Fibers
The chief characteristic of the EBD is its ability to form a
tight complex with serum albumin within seconds after its
injection into the bloodstream (Reeve, 1957). In view of
the tight association between EBD and albumin, areas of
blue macroscopic staining were taken to represent regions
of albumin uptake into muscle fibers. To demonstrate that
EBD-positive muscle fibers in mdx mice do take up albu-
min, we stained cryosections for albumin. We could show
that the same fibers that took up the dye were also positive
for albumin staining (Fig. 4 A).
To further demonstrate that serum proteins cross into
damaged fibers, we stained skeletal muscle sections of un-
injected mice with antibodies against albumin (65 kD),
IgG (150 kD), and IgM (900 kD; Fig. 4 B). In all muscles
examined, positive staining with anti–mouse serum albumin
antibodies, anti–mouse IgG antibodies, and anti–mouse IgM
antibodies was observed in the endo- and perimysium (Fig.
4 B). Control mice did not show intracellular fiber staining
with these antibodies. On the other hand, mdx mice showed
intracellular staining for all antibodies within a part of their
muscle fibers (Fig. 4 B). The staining patterns for the serum
markers were strikingly similar to the patterns of EBD dep-
osition. Intracellular staining was diffusely distributed
across the myofiber cytoplasm, although sometimes it ap-
peared to be localized to the fiber periphery. Examination
of serial sections showed that the pattern of intracellular
staining was similar for albumin, IgG, and IgM (Fig. 4 B).
The Role of Muscle Fiber Membrane Damage in 
Transgenic/mdx Mice
To test the importance of distinct dystrophin domains for
maintaining sarcolemmal integrity, we injected EBD into
transgenic lines of mdx mice expressing different portions
of the dystrophin molecule (Fig. 5). Intravenous injection
of EBD into Dp71 mice led to incorporation of the tracer
into skeletal muscles by visual inspection. The intensity
and the extent of stained regions was similar to that of
mdx mice. In contrast, D17-48 transgenic/mdx mice, which
mimic the dystrophin mutation in an extremely mild case
of Becker muscular dystrophy (England et al., 1990;
Phelps et al., 1995), and D71-74 transgenic/mdx mice,
which have been reported to show no dystrophic pheno-
type up to at least 2 yr of age (Rafael et al., 1994, 1996),
Figure 3. EBD staining on 7-mm cryosections of mdx cardiac
muscle. EBD-positive cardiomyocytes were detected in 8 out of
16 mdx mice but never in control animals. One intravenously in-
jected 4-wk-old animal showed large areas of dye uptake into the
myocardium (a), whereas in other mice, smaller regions of EBD-
positive fibers were found in the ventricular walls (b). Cardiac
dye uptake in intraperitoneally injected mdx mice (c, 10-mo-old
animal) demonstrated that the fiber damage was caused by the
underlying disease and not by a volume overload of intravenously
administered dye, leading to a cardiac infarct. Bars, 100 mm.The Journal of Cell Biology, Volume 139, 1997 380
did not demonstrate macroscopic dye uptake after intrave-
nous injections. The D3-7 transgenic mdx mice, in which
the expression of a full-length dystrophin construct de-
leted for the amino-terminal, actin-binding domain im-
proves the mdx pathology to a mild “Becker-like” pheno-
type (Corrado et al., 1996), did take up EBD into skeletal
muscle fibers. However, sarcolemmal damage in D3-7
transgenic/mdx mice, as assessed by EBD incorporation,
appeared less severe than in the mdx or the Dp71 mice
(Fig. 5). The femoral quadriceps muscle and the diaphragm
Figure 4. Loss of membrane integrity is indicated by intracellular
staining of serum proteins. EBD-positive fibers in skeletal muscle
from  mdx mice also showed positive staining with antibodies
against albumin on the same section. (A) Double staining for
EBD (a) and albumin (b) in an 8-wk-old mdx mouse. (B) Skeletal
muscle of 10-wk-old mice that were not injected with EBD were
studied for uptake of serum proteins into muscle fibers. Immuno-
histochemical staining of 7-mm femoral quadriceps cryosection
from uninjected normal and mdx mice with antibodies against
mouse IgG (a and b), mouse IgM (c and d), and mouse albumin
(e and f) showed accumulation of the serum markers in mdx skel-
etal muscle. No difference of protein uptake into muscle fibers
was detected between control and dy/dy mice. Bar, 50 mm.
Figure 5. EBD staining on 7-mm cryosection of skeletal muscle
from four transgenic/mdx mice. The top portion of the picture
shows a model of the normal dystrophin gene. The femoral quad-
riceps muscle of the Dp71 mouse (20 wk old) revealed the same
amount of fiber damage in the EBD assay as the original mdx
mutant. Mice with a deletion of dystrophin exons 71–74 (17 wk
old) did not show significantly more dye uptake into the femoral
quadriceps muscle than seen in control animals. The D17-48
transgenic/mdx mouse (9 wk old), which has a deletion in the rod
domain of dystrophin, showed few dye-positive fibers in the
quadriceps femoris muscle. The D3-7 transgenic/mdx mouse (10
wk old), which has a deletion in the amino-terminal actin-binding
domain of dystrophin, showed dye-positive fibers in the dia-
phragm (D3-7), as well as in the quadriceps femoris muscle. Bar,
50 mm.Straub et al. Sarcolemmal Damage in Muscular Dystrophy 381
were the only muscles in which dye accumulation was visu-
ally observed in D3-7 transgenic/mdx mice.
Fluorescence microscopy analysis of Dp71 skeletal mus-
cle cryosections revealed no difference in the amount of
EBD-positive muscle fibers between Dp71 and mdx mice
(Fig. 5). In the D17-48 transgenic/mdx mice and the D71-74
transgenic/mdx mice, fluorescent microscopy analysis re-
vealed some EBD-positive fibers in the diaphragm and the
femoral quadriceps muscle, although never to the extent
of the mdx (Fig. 5). In D3-7 transgenic/mdx mice, the num-
ber of EBD-positive fibers in macroscopically blue areas
of skeletal muscle was smaller, and the fibers were more
loosely distributed compared to sections of injected mdx
or Dp71 mice (Fig. 5).
dy/dy and dy2J/dy2J Mice Maintain Plasma
Membrane Integrity
Interestingly, dy/dy and dy2J/dy2J mice did not reveal dye
incorporation into skeletal muscles (Fig. 6). Because of the
increase in connective tissue in dystrophic muscle, the
mice showed a blue aspect resulting from dye accumula-
tion into their connective tissue. Otherwise, we did not de-
tect any dye accumulation in the inspected muscles (Table I).
The sections from injected dy/dy and dy2J/dy2J mice
showed only occasional EBD-positive fibers in the dia-
phragm (Fig. 7) or the femoral quadriceps muscle (Fig. 6 f).
The low level of intracellular fiber staining was a constant
feature of the muscles we examined from dy/dy and dy2J/
dy2J mice (Table I). The dye-positive fibers always showed
necrotic features according to H&E staining (Fig. 7). They
appeared singly and never showed grouping, which is char-
acteristic for mdx or Dp71 transgenic/mdx mice (Fig. 6).
There were no differences in the extent or intensity of dye
accumulation and distribution in skeletal muscles between
dy/dy and dy2J/dy2J mice. In contrast to mdx mice, we never
found EBD staining in the cardiac muscle of dy/dy and
dy2J/dy2J mice.
Figure 6. Macroscopic and microscopic evaluation of EBD staining after intravenous dye injection into 3-mo-old normal control (a and
b), mdx (c and d), and dy/dy (e and f) mice. Uptake of dye into the hind legs of the mice was examined 6 h after the injection. The hind
legs were fixed in a 8% formaldehyde solution. In contrast to mdx mice (c), dy/dy (e) or dy2J/dy2J mice never showed localized EBD up-
take into skeletal muscles by visual inspection. Blue coloration of dy/dy and dy2J/dy2J mice observed by macroscopic evaluation was
caused by dye uptake into the connective tissue, which is increased in these dystrophic animals. This finding was confirmed by fluores-
cence microscopy analysis of 7-mm cryosections from the quadriceps femoris muscle of injected animals. Grouped EBD-positive fibers
were only detected in mdx mice (d), whereas cryosections from normal control mice (b), dy/dy (f), or dy2J/dy2J mice did not show dye up-
take into groups of muscle fibers. On cryosections of dy/dy (f) mice, single necrotic fibers showed EBD staining by fluorescence micros-
copy. Bar, 50 mm.The Journal of Cell Biology, Volume 139, 1997 382
Different Patterns of Sarcolemmal
Disruption in Patients with DMD and Laminin a2
Chain–deficient CMD
To test whether the findings in the animal models could be
reproduced in patients with DMD and laminin a2 chain–
deficient CMD, we tested cryosections from diagnostic bi-
opsies with antibodies against IgG and IgM. In three out
of eight needle biopsies from DMD patients, we found
IgG- and IgM-positive muscle fibers (Fig. 8). The globulin-
positive fibers showed the same grouping pattern as that
described for the mdx mice. On normal human muscle sec-
tions, IgG and IgM were detected only in the endo- and
perimysium (Fig. 8). Interestingly, not all IgG-positive fi-
bers in DMD patients showed IgM uptake into the cyto-
plasm (Fig. 8, arrow), possibly because of the different
sizes of the molecules. This finding was confirmed by look-
ing at serial sections of the biopsy samples. In the biopsies
of eight patients with laminin a2 chain–deficient CMD, we
never found grouped fibers with positive staining for Igs.
Two of the CMD patients had a deletion in the LAMA2
gene similar to the dy2J mice and were previously charac-
terized (Allamand et al., 1997). Single fibers with an intra-
cellular staining signal for Igs were detected on CMD bi-
opsies and showed morphological features of necrosis.
Discussion
Previous findings support the idea that one function of the
DGC is to provide mechanical reinforcement of the sarco-
lemma and to maintain membrane integrity during cycles
of contraction and relaxation (Weller et al., 1990; Clarke
et al., 1995; Petrof et al., 1993). To test the involvement of
sarcolemmal damage in the pathogenesis of muscle fiber
degeneration and necrosis, we injected animal models for
muscular dystrophy with EBD. Intracellular accumulation
of the dye in skeletal muscle fibers indicated loss of sar-
colemmal integrity due to plasma membrane disruptions.
As a further test of altered membrane permeability, we ex-
amined the intracellular deposition of serum proteins in
skeletal muscle fibers in the murine models and in patients
with DMD and CMD.
Our results demonstrated that focal plasma membrane
defects have actually occurred in vivo and not, as argued,
during biopsy (Bradley and Fulthorpe, 1978). The diffuse
intracellular distribution of the tracer implied a break in
the structural integrity of the surface membrane. Interest-
ingly, sarcolemmal permeability in certain muscles, includ-
ing the heart, not only appeared to vary from animal to an-
imal, but also showed alterations between the same muscle
groups in the limbs of one animal. These findings suggest
that in addition to the genetic disposition, sarcolemmal
damage is also a function of environmental influences,
such as activity in the time period between dye injection
and death. By intravenous and intraperitoneal injection of
EBD into mdx mice, we also demonstrated loss of mem-
brane integrity in cardiomyocytes. These results show that
the tracer technique may be helpful in evaluating the dis-
tribution and pattern of pathologic lesions in cardiac mus-
cle, and that it might be a useful tool in studies of cardiac
infarctions.
Table I. Analysis of EBD-injected Mice
Mice
Macroscopic
skeletal muscle
staining
Microscopic staining
Femoral
quadriceps Soleus
Pectoralis
major Diaphragm
control (n 5 16) 0% –* – – –
mdx (n 5 16) 100% 11§ 1‡ 11
dy/dy (n 5 6) 0% – – – –
dy2J/dy2J(n 5 6) 0% – – – –
3–6 h after intravenous EBD injection, skinned animals were visually inspected for
dye uptake into skeletal muscles. Dye-positive muscles were easily detected by local-
ized blue coloration. Only mdx mice always (100%) showed dye uptake into at least
one muscle by macroscopic evaluation. This was in strong contrast to normal control,
dy/dy, and dy2J/dy2J mice. The dy/dy and dy2J/dy2J mice mainly showed dye uptake
into their connective tissue. Clear macroscopic EBD staining of skeletal muscles was
never (0%) detected in these animals. This finding was confirmed by fluorescence mi-
croscopy analysis of 7-mm cryosections from the quadriceps femoris, soleus, pectora-
lis major, and diaphragm muscles of injected animals. Fiber counts of EBD-positive
muscle fibers were done independently by two investigators. The number of EBD-
positive fibers in a muscle was compared to the total number of fibers. Assessment of
dye uptake into the diaphragm was not performed on six intraperitoneally injected
mdx mice.
*Less then 1% of the muscle fibers were EBD positive.
‡Less then 10% of the muscle fibers were EBD positive.
§More then 10% of the muscle fibers were EBD positive.
Figure 7. EBD staining (a) and H&E staining (b) on 7-mm cryo-
sections from a 7-wk-old dy/dy diaphragm. The few EBD-posi-
tive fibers in dy/dy skeletal muscle always showed necrotic fea-
tures in the corresponding H&E stain. The nuclei of infiltrating
immune cells were also detected by the EBD. Bars, 100 mm.Straub et al. Sarcolemmal Damage in Muscular Dystrophy 383
According to our findings and previous studies (Mokri
and Engel, 1975; Karpati and Carpenter, 1982), we suggest
that EBD-positive fibers in mdx mice do not inevitably
lead to necrosis of the whole fiber, but often reflect degen-
erating fibers with a potential for regeneration. Segmental
loss of sarcolemmal integrity or plasma membrane disrup-
tions confined to a small region of the cell will allow the
dye to cross into a muscle fiber and to diffuse along the
longitudinal axis (Fig. 2 d). In the mdx or Dp71 mice, most
of the EBD-positive fibers presumably undergo a stage of
segmental necrosis and regeneration, and just a small
group of dye positive fibers will undergo full-length fiber
necrosis, depending on the amount and size of membrane
disruptions. With the tracer technique, we demonstrated
that in the femoral quadriceps muscle of mdx mice, .70%
of the myofibers can show EBD uptake (Fig. 2 a). In addi-
tion, we could demonstrate that a number of EBD-posi-
tive fibers showed normal morphology by H&E staining
(Fig. 2 f). It has been suggested that membrane defects al-
lowed the influx of calcium-rich extracellular fluid into the
muscle cells that caused hypercontraction and also initi-
ated fiber necrosis (Mokri and Engel, 1975; Schmalbruch,
1975). Our results, on the other hand, indicate that hyper-
contracted fibers did not generally show primary plasma
membrane defects, and they did not in and of themselves
cause secondary rupture of the muscle fiber plasma mem-
brane (Fig. 2, e and f). The interesting observation of
grouped EBD fibers in cross-sections of mdx and Dp71
mice may reflect the fact that the fibers branch extensively
(Bell and Conen, 1968; Schmalbruch, 1984; Head et al.,
1992), and that the dye may diffuse into all branches of a
fiber if one branch loses sarcolemmal integrity. Some of
the faintly fluorescent muscle fibers may be segments ad-
jacent to a damaged site from where the EBD diffused
into the surviving stumps.
Furthermore, we were able to demonstrate that EBD-
positive fibers were rendered transiently or permanently
permeable to extracellular serum albumin and other se-
rum proteins. These findings were confirmed in uninjected
animals and in patient samples with muscular dystrophy
(Figs. 3 and 6). The different molecular weights and sizes
of these serum markers allowed us to draw conclusions
about the size of sarcolemmal disruptions in affected fi-
bers. The 900 kD IgM molecules were able to cross into
the same fibers as 65 kD albumin proteins. The accumula-
tion of serum proteins in the sarcoplasm also indicates that
they may play a role in the pathogenic mechanism that fi-
nally leads to cell death.
As assessed by intracellular uptake of EBD, the mdx
and Dp71 mice showed the most severe sarcolemmal dis-
ruptions. According to our results in the transgenic mice,
the rod domain of dystrophin and the COOH-terminal do-
main encoded by exons 71–74 do not seem to be as impor-
tant for membrane integrity. Expression of dystrophin de-
leted for the actin-binding sites encoded by exons 3–7 at or
above normal dystrophin levels in the D3-7 transgenic/mdx
mice resulted in a mild phenotype (Corrado et al., 1996)
with relatively few EBD-positive fibers. The findings in
the transgenic mice were particularly interesting with re-
spect to the Dp71 mouse. Recent studies on the interac-
tion of dystrophin with F-actin identified a novel F-actin–
binding site near the middle of the dystrophin rod domain,
and a model was proposed in which dystrophin binds F-actin
in a manner analogous to actin side-binding proteins (Ry-
bakova et al., 1996). In contrast to the D3-7 transgenic/mdx
mouse, the Dp71 mouse lacks all known actin-binding do-
Figure 8. Immunohistochem-
ical staining of 7-mm cryosec-
tion from normal human
skeletal muscle, DMD skele-
tal muscle, and skeletal mus-
cle from patients with lami-
nin a2 chain–deficient CMD
with antibodies against hu-
man IgG and IgM. The
plasma proteins showed in-
tracellular fiber staining in
the quadriceps femoris mus-
cle from DMD biopsies, indi-
cating loss of membrane in-
tegrity. Positive staining of
grouped fibers was only de-
tected in DMD patients. The
antibody against human IgG
did not show the same stain-
ing intensity as the antibody
against human IgM. Interest-
ingly, not all IgG-positive fi-
bers took up IgM molecules
(arrow), indicating different
sizes of membrane disrup-
tions. This observation was
confirmed on serial sections
throughout the damaged area.
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mains of the dystrophin molecule, but is sufficient to re-
store the DGC at the sarcolemma. Our data indicate that
the preservation of the DGC at the sarcolemma is not suf-
ficient to prevent membrane disruptions. Taken together,
these results indicate that cytoskeletal and sarcolemmal
attachment of dystrophin might be a necessary require-
ment to prevent serious fiber damage. If these connections
are altered, physiologic mechanical forces might already
overstress the fragile membrane structure and cause focal
plasma membrane disruptions. Pasternak et al. (1995)
have demonstrated that the lack of dystrophin causes a
substantial reduction in the stiffness of living muscle cells.
In their model, dystrophin acts as a molecular spring that
could redistribute stresses imposed locally on the sarco-
lemma over a wide area of the cell.
Most interestingly, the dy/dy and dy2J/dy2J mice showed
no signs of sarcolemmal damage despite their severe clini-
cal phenotype. The fact that we did not find a more signifi-
cant dye accumulation in skeletal muscles of dy or dy2J
mice as compared to normal controls indicated that plasma
membrane disruptions do not seem to play a role in mus-
cle cell degeneration of these animals. In the dy2J mouse,
the deletion in the lama2 locus is located in the NH2-termi-
nal domain IV, which is presumed to be involved in self-
aggregation of laminin-2 heterotrimers, as in the case of
laminin 1 (Schittny and Yurchenco, 1990). This mutation
could disrupt the formation of the laminin-2 network in
the muscle basal lamina, which could weaken or eliminate
the linkage between the extracellular matrix and the mus-
cle fiber surface. Our studies demonstrate that the laminin
alteration does not effect the plasma membrane integrity.
This finding is supported by electron microscopic studies
suggesting that the muscular basement membrane in dy/dy
mice is fragmented but plasma membrane disruptions do
not occur (Xu et al., 1994a). Similar findings have also
been reported in patients with congenital muscular dystro-
phy with laminin a2 chain deficiency (Minetti et al., 1996).
The small size of the dy/dy and the dy2J/dy2J mice, their
severe clinical phenotype, and the fact that they do not
show dye accumulation in their skeletal muscles suggests
that laminin-2 may transmit a specific signal to the muscle
cell required for muscle function rather than play a me-
chanical role in maintaining membrane integrity. Laminin
molecules are known to be multifunctional, performing
key roles in development, differentiation, and migration
through their ability to interact with cells via cell surface
receptors, including a-dystroglycan. In their association
with the DGC, these molecules do not seem to influence
the mechanical functions of the sarcolemma.
Plasma membrane disruptions might be an alternative
way into and out of the sarcoplasm and subsequently serve
as a route for the release of growth factors (McNeil and
Khakee, 1992) and other myocyte-derived autocrine mole-
cules. It was proposed that such cell-mediated processes
are one way to stimulate the adjustment of muscle fibers
to exercise and to repair membrane damage (Clarke et al.,
1995; Kaye et al., 1996). Release of growth factors in skele-
tal muscle might be directly coupled to plasma membrane
disruptions, whether induced by exercise or caused by re-
duced sarcolemmal stiffness (McNeil et al., 1989; Muth-
ukrishnan et al., 1991). In this respect, plasma membrane
disruptions might be beneficial for skeletal muscle regen-
eration and initiate not only damage, but also the cellular
processes necessary for its repair. The EBD-injected mice
strains that incorporated the dye into skeletal muscle fi-
bers and hence had sarcolemmal disruptions all showed a
benign phenotype, hypertrophic muscle fibers, and a nor-
mal to increased body weight. Consistent with this hypoth-
esis, the dy/dy and dy2J/dy2J mice, which show severe clini-
cal symptoms, did not reveal major dye uptake, do not
show hypertrophic fibers, are small in size, and weigh less
than their wild-type littermates.
In conclusion, we demonstrate that loss of plasma mem-
brane integrity in skeletal muscle fibers may play a pri-
mary role in the course of the Xp21 muscular dystrophies.
Membrane disruptions induced by mechanical forces may
provide a route into and out of the sarcoplasm distinct
from the conventional, membrane-bound routes of endo-
and exocytosis (McNeil and Khakee, 1992). In diseased
muscle with a higher muscle membrane vulnerability, this
route may be of technical importance for introducing for-
eign therapeutic substances or even genes into damaged
muscle fibers. Sarcolemmal permeability is of principal in-
terest with regard to its role in the genesis of muscle cell
degeneration and necrosis, and as this role becomes better
defined, in the prevention and treatment of disease.
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